<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01431014</url>
  </required_header>
  <id_info>
    <org_study_id>99-2811-B-182A-003</org_study_id>
    <secondary_id>CGMH-IRB-100-2191B</secondary_id>
    <nct_id>NCT01431014</nct_id>
  </id_info>
  <brief_title>Effect of Steroid for the Postoperative Swelling After Orthognathic Surgery</brief_title>
  <official_title>The Effect of Steroid on Reducing Facial Swelling After Orthognathic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative swelling is one of most common concerns to plastic and oromaxillary surgeons
      after orthognathic surgery. The purpose of this study is to develop a steroid regimen
      protocol for minimizing postoperative facial swelling after orthognathic surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative swelling is an annoying problem after orthognathic surgery. There are two
      reasons to minimize postoperative swelling. The first is a functional consideration.
      Orthognathic surgery is performed in oromaxillary area, and consequently swelling in this
      area can compromise airway. The second is esthetic one, as patients feel uncomfortable and
      embarrassing with a swollen face. Reducing facial swelling after orthognathic surgery helps
      to reduce airway complication and patient down time.

      Several methods are used to reduce postoperative facial swelling, including controlled
      hypotension during operation, meticulous operative procedures, postoperative facial ice
      packing, head elevation, and suction drainage. Perioperative use of steroid has been applied
      for reduction of facial swelling after oral surgery and 3rd molar extraction.
      Cyclooxygenase-1 (COX1) and COX2 have been reported to be important enzymes for inflammatory
      process, and steroids inhibit their synthesis, consequently reducing postoperative edema.
      Steroid has also been used to decrease edema after orthognathic surgery, as well as to reduce
      pain, nausea and vomiting.

      There were three randomized controlled studies looking at the effect of steroid on
      postoperative facial swelling after orthognathic surgery, separately by Dr. Weber et al,
      Peillon et al, and Munro et al. However, the results were controversial. The first two
      studies concluded that the steroid use could reduce facial swelling. The other one did not
      find significant difference between the experimental and control groups. Another limitation
      of the previous studies was that they all used two-dimensional or non-objective methods for
      evaluation of the amount of swelling, which could be less accurate. Three-dimensional
      photogrammetry has been introduced in recent years, and has obtained satisfactory results
      over the conventional methods. The investigators have experience of applying the device for
      facial surface study, and the accuracy has been validated in our imaging laboratory.

      The purpose of this study is to determine the effect of steroid for reduction of
      postoperative facial swelling determined by three-dimensional photographic method. 3dMD face
      scanner will be used. The 3-dimensional method makes no harm to patients. Patients will be
      seated during scanning and thus reducing possible inconvenience. There is no radiation hazard
      with this method. The image acquisition time is 2 milliseconds or less, and therefore no
      concern of motion artifacts. The first part of this study is to get information about the
      swelling curve after orthognathic surgery. 3dMD face scanning will be performed 5 times
      postoperatively every 12 hours after 24 hours of operation. When the postoperative timing of
      maximal facial swelling is obtained, the investigators will proceed to perform the second
      part of study, and the number of facial scanning is reduced. The second part of study
      involves recruiting 70 patients with prognathism. The patients will be carefully screened and
      selected by craniofacial surgeons. The patients will take preoperative and postoperative 3dMD
      image scanning. The recovery course and clinical outcome will be monitored. 3dMD face image
      data analysis will be performed for quantitative comparisons between the experimental and
      control groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of Perioperative Steroid for the Postoperative Swelling After Orthognathic Surgery</measure>
    <time_frame>1 year</time_frame>
    <description>Measure of facial swelling will be performed using 3-dimensional photogrammetry. The 3d photo acquisition is non-invasive without radiation concern. The images will be taken before and after surgery to measure and compare the degree of facial swelling. Side effects from the steroid use are expected to be low under normal clinical dosage, but will also be monitored. Symptoms of wound infection, psychosis, and prolonged wound healing will be studied. There should be no long term complication, since the steroid use is one single dose.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Swelling</condition>
  <arm_group>
    <arm_group_label>Dexamethasone&quot;low-dose&quot;</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone&quot;high-dose&quot;</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone&quot;low-dose&quot;</intervention_name>
    <description>5mg</description>
    <arm_group_label>Dexamethasone&quot;low-dose&quot;</arm_group_label>
    <other_name>dexan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone&quot;high-dose&quot;</intervention_name>
    <description>15 mg</description>
    <arm_group_label>Dexamethasone&quot;high-dose&quot;</arm_group_label>
    <other_name>dexan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who receive LeFort I osteotomy of maxilla and bilateral sagittal split
             osteotomy of mandible

        Exclusion Criteria:

          -  patients with local or systemic diseases

          -  patients taking aspirin, steroid, nonsteroidal anti-inflammatory drugs, or having
             contraindications for steroids

          -  patients with history of psychosis

          -  patients with active or chronic infection

          -  patients with active or latent peptic ulcer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lun-Jou Lo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chang Gung Memorial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hye-Young Kim, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Chang Gung Memorial Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital</name>
      <address>
        <city>Taoyuan</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <results_reference>
    <citation>Kau CH, Cronin AJ, Richmond S. A three-dimensional evaluation of postoperative swelling following orthognathic surgery at 6 months. Plast Reconstr Surg. 2007 Jun;119(7):2192-9.</citation>
    <PMID>17519721</PMID>
  </results_reference>
  <results_reference>
    <citation>van Loon B, Maal TJ, Plooij JM, Ingels KJ, Borstlap WA, Kuijpers-Jagtman AM, Spauwen PH, Berg√© SJ. 3D Stereophotogrammetric assessment of pre- and postoperative volumetric changes in the cleft lip and palate nose. Int J Oral Maxillofac Surg. 2010 Jun;39(6):534-40. doi: 10.1016/j.ijom.2010.03.022. Epub 2010 Apr 27.</citation>
    <PMID>20427150</PMID>
  </results_reference>
  <results_reference>
    <citation>Schaberg SJ, Stuller CB, Edwards SM. Effect of methylprednisolone on swelling after orthognathic surgery. J Oral Maxillofac Surg. 1984 Jun;42(6):356-61.</citation>
    <PMID>6585512</PMID>
  </results_reference>
  <results_reference>
    <citation>Meyer-Marcotty P, Alpers GW, Gerdes AB, Stellzig-Eisenhauer A. Impact of facial asymmetry in visual perception: a 3-dimensional data analysis. Am J Orthod Dentofacial Orthop. 2010 Feb;137(2):168.e1-8; discussion 168-9. doi: 10.1016/j.ajodo.2008.11.023.</citation>
    <PMID>20152669</PMID>
  </results_reference>
  <results_reference>
    <citation>Rana M, Gellrich NC, Joos U, Piffk√≥ J, Kater W. 3D evaluation of postoperative swelling using two different cooling methods following orthognathic surgery: a randomised observer blind prospective pilot study. Int J Oral Maxillofac Surg. 2011 Jul;40(7):690-6. doi: 10.1016/j.ijom.2011.02.015. Epub 2011 Mar 15.</citation>
    <PMID>21411291</PMID>
  </results_reference>
  <results_reference>
    <citation>Chegini S, Dhariwal DK. Review of evidence for the use of steroids in orthognathic surgery. Br J Oral Maxillofac Surg. 2012 Mar;50(2):97-101. doi: 10.1016/j.bjoms.2010.11.019. Epub 2011 Feb 12. Review.</citation>
    <PMID>21316821</PMID>
  </results_reference>
  <results_reference>
    <citation>Dan AE, Thygesen TH, Pinholt EM. Corticosteroid administration in oral and orthognathic surgery: a systematic review of the literature and meta-analysis. J Oral Maxillofac Surg. 2010 Sep;68(9):2207-20. doi: 10.1016/j.joms.2010.04.019. Epub 2010 Jun 29. Review.</citation>
    <PMID>20591548</PMID>
  </results_reference>
  <results_reference>
    <citation>Bourke DL. Use of steroids during orthognathic surgery. J Oral Maxillofac Surg. 1986 Jan;44(1):2-3.</citation>
    <PMID>3455720</PMID>
  </results_reference>
  <results_reference>
    <citation>Weber CR, Griffin JM. Evaluation of dexamethasone for reducing postoperative edema and inflammatory response after orthognathic surgery. J Oral Maxillofac Surg. 1994 Jan;52(1):35-9.</citation>
    <PMID>8263640</PMID>
  </results_reference>
  <results_reference>
    <citation>Mocan A, Ki≈üni≈üci R, U√ßok C. Stereophotogrammetric and clinical evaluation of morbidity after removal of lower third molars by two different surgical techniques. J Oral Maxillofac Surg. 1996 Feb;54(2):171-5.</citation>
    <PMID>8604065</PMID>
  </results_reference>
  <results_reference>
    <citation>Esen E, Ta≈üar F, Akhan O. Determination of the anti-inflammatory effects of methylprednisolone on the sequelae of third molar surgery. J Oral Maxillofac Surg. 1999 Oct;57(10):1201-6; discussion 1206-8.</citation>
    <PMID>10513866</PMID>
  </results_reference>
  <results_reference>
    <citation>Seo K, Tanaka Y, Terumitsu M, Someya G. Efficacy of steroid treatment for sensory impairment after orthognathic surgery. J Oral Maxillofac Surg. 2004 Oct;62(10):1193-7.</citation>
    <PMID>15452804</PMID>
  </results_reference>
  <results_reference>
    <citation>Day CJ, Robert T. Three-dimensional assessment of the facial soft tissue changes that occur postoperatively in orthognathic patients. World J Orthod. 2006 Spring;7(1):15-26.</citation>
    <PMID>16548302</PMID>
  </results_reference>
  <results_reference>
    <citation>Laureano Filho JR, Maurette PE, Allais M, Cotinho M, Fernandes C. Clinical comparative study of the effectiveness of two dosages of Dexamethasone to control postoperative swelling, trismus and pain after the surgical extraction of mandibular impacted third molars. Med Oral Patol Oral Cir Bucal. 2008 Feb 1;13(2):E129-32.</citation>
    <PMID>18223530</PMID>
  </results_reference>
  <results_reference>
    <citation>Huam√°n ET, Juvet LM, Nastri A, Denman WT, Kaban LB, Dodson TB. Changing patterns of hospital length of stay after orthognathic surgery. J Oral Maxillofac Surg. 2008 Mar;66(3):492-7. doi: 10.1016/j.joms.2007.08.025.</citation>
    <PMID>18280382</PMID>
  </results_reference>
  <results_reference>
    <citation>Meisami T, Musa M, Keller MA, Cooper R, Clokie CM, S√†ndor GK. Magnetic resonance imaging assessment of airway status after orthognathic surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Apr;103(4):458-63. Epub 2006 Oct 27.</citation>
    <PMID>17395062</PMID>
  </results_reference>
  <results_reference>
    <citation>Sotto-Maior BS, Senna PM, de Souza Picorelli Assis NM. Corticosteroids or cyclooxygenase 2-selective inhibitor medication for the management of pain and swelling after third-molar surgery. J Craniofac Surg. 2011 Mar;22(2):758-62. doi: 10.1097/SCS.0b013e318207f3fe.</citation>
    <PMID>21415660</PMID>
  </results_reference>
  <results_reference>
    <citation>Daniels SE, Desjardins PJ, Bird SR, Smugar SS, Tershakovec AM. Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction: results of two randomized, double-blind, placebo-controlled, single-dose studies. Clin Ther. 2006 Jul;28(7):1022-34.</citation>
    <PMID>16990080</PMID>
  </results_reference>
  <results_reference>
    <citation>Fleming PS, Flood TR. Steroid-induced psychosis complicating orthognathic surgery: a case report. Br Dent J. 2005 Nov 26;199(10):647-8.</citation>
    <PMID>16311560</PMID>
  </results_reference>
  <results_reference>
    <citation>Galen DM, Beck M, Buchbinder D. Steroid psychosis after orthognathic surgery: a case report. J Oral Maxillofac Surg. 1997 Mar;55(3):294-7.</citation>
    <PMID>9054921</PMID>
  </results_reference>
  <results_reference>
    <citation>Precious D, Armstrong J, Morrison A, Field C. The incidence of total hip replacement in orthognathic surgery patients receiving short-term steroid therapy. J Oral Maxillofac Surg. 1992 Sep;50(9):956-7.</citation>
    <PMID>1506971</PMID>
  </results_reference>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2011</study_first_submitted>
  <study_first_submitted_qc>September 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2011</study_first_posted>
  <results_first_submitted>February 6, 2014</results_first_submitted>
  <results_first_submitted_qc>February 6, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 21, 2014</results_first_posted>
  <last_update_submitted>February 6, 2014</last_update_submitted>
  <last_update_submitted_qc>February 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>orthognathic surgery</keyword>
  <keyword>steroid</keyword>
  <keyword>swelling</keyword>
  <keyword>3-dimensional photogrammetry</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Dexamethasone&quot;High-dose&quot;</title>
          <description>15mg
Dexamethasone&quot;high-dose&quot; : 15 mg</description>
        </group>
        <group group_id="P2">
          <title>Dexamethasone&quot;Low-dose&quot;</title>
          <description>5mg
Dexamethasone&quot;low-dose&quot; : 5mg</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Dexamethasone&quot;High-dose&quot;</title>
          <description>15mg
Dexamethasone&quot;high-dose&quot; : 15 mg</description>
        </group>
        <group group_id="B2">
          <title>Dexamethasone&quot;Low-dose&quot;</title>
          <description>5mg
Dexamethasone&quot;low-dose&quot; : 5mg</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="31"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="56"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.16" spread="4.19"/>
                    <measurement group_id="B2" value="20.92" spread="4.79"/>
                    <measurement group_id="B3" value="22.16" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Taiwan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Effect of Perioperative Steroid for the Postoperative Swelling After Orthognathic Surgery</title>
        <description>Measure of facial swelling will be performed using 3-dimensional photogrammetry. The 3d photo acquisition is non-invasive without radiation concern. The images will be taken before and after surgery to measure and compare the degree of facial swelling. Side effects from the steroid use are expected to be low under normal clinical dosage, but will also be monitored. Symptoms of wound infection, psychosis, and prolonged wound healing will be studied. There should be no long term complication, since the steroid use is one single dose.</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone&quot;High-dose&quot;</title>
            <description>15mg Dexamethasone&quot;high-dose&quot; : 15 mg</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone&quot;Low-dose&quot;</title>
            <description>5mg Dexamethasone&quot;low-dose&quot; : 5 mg</description>
          </group>
        </group_list>
        <measure>
          <title>Effect of Perioperative Steroid for the Postoperative Swelling After Orthognathic Surgery</title>
          <description>Measure of facial swelling will be performed using 3-dimensional photogrammetry. The 3d photo acquisition is non-invasive without radiation concern. The images will be taken before and after surgery to measure and compare the degree of facial swelling. Side effects from the steroid use are expected to be low under normal clinical dosage, but will also be monitored. Symptoms of wound infection, psychosis, and prolonged wound healing will be studied. There should be no long term complication, since the steroid use is one single dose.</description>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>36 hours postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="167.06" spread="55.93"/>
                    <measurement group_id="O2" value="190.73" spread="78.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1week postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.39" spread="30.14"/>
                    <measurement group_id="O2" value="57.62" spread="36.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1month postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.85" spread="19.40"/>
                    <measurement group_id="O2" value="19.34" spread="16.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Dexamethasone&quot;Low-dose&quot;</title>
          <description>5mg
Dexamethasone&quot;low-dose&quot;: 5mg</description>
        </group>
        <group group_id="E2">
          <title>Dexamethasone&quot;High-dose&quot;</title>
          <description>15mg
Dexamethasone&quot;high-dose&quot;: 15 mg</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lun-Jou Lo, MD,Hye-Young Kim, MD</name_or_title>
      <organization>Chang Gung Memorial Hospital</organization>
      <email>lunjoulo@cgmh.org.tw</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

